BioML Challenge 2024: Bits to Binders
Published:
CAR-T cell therapy is a cancer treatment where a patient’s T cells are genetically modified to fight cancer. The process involves extracting T cells from the patient, engineering them to express a Chimeric Antigen Receptor (CAR) specifically targeting cancer cells, and reintroducing these modified cells into the patient’s body. Once inside the patient’s body, the CAR-T cells recognize and attack the cancer cells, helping to eliminate the tumor. An open question in the field of CAR-T cell therapy is how to design effective antigen-binding domains that can specifically target cancer antigens and trigger a robust immune response.